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Abstract
Background: Recently, damage to the sperm DNA has been studied as it is associated with reduced fertilization
rates, embryo quality, and pregnancy rates, also higher rates of spontaneous miscarriage.
Objective: To develop a diagnostic method in predicting male infertility.
Material and Methods: The design of this study is cross-sectional. Data were retrieved from medical records of Yasmin
IVF Clinic Dr. Cipto Mangunkusumo General Hospital and Daya Medika Infertility Clinic from January to December 2015.
Subjects were selected by consecutive sampling and divided into two groups: infertile and fertile. Sperm deoxyribonucleic
acid fragmentation index (DFI) was determined by sperm chromatin dispersion (SCD) method using Halosperm® Kit.
Results: There were 114 subjects (36 fertile and 78 infertile) selected into this study. We found no significant difference
in the age between both of groups. The median value of sperm DFI in infertile group was significantly higher, 29.95
(26.6–34.3)%, compared to 19.90 (15.6–24.4)% of the fertile group, with p < 0.001. Area Under Curve (AUC) of sperm DFI,
0.862 (95% CI 0.783, 0.941), was higher than concentration (AUC 0.744; 95% CI 0.657, 0.831), motility (AUC 0.668; 95% CI
0.572, 0.765), and morphology (AUC 0.718; 95% CI 0.697, 0.864) of the semen analysis. At the cut-off point of 26.1%, the
sperm DFI had sensitivity of 80.8% (95% CI; 70.0, 88.5), specificity of 86.1% (95% CI; 69.7, 94.8), positive predictive value
(PPV) of 92.6% (95% CI; 83.0, 97.3), negative predictive value (NPV) of 67.4% (95% CI; 51.9, 80.0), positive likelihood ratio
(PLR) of 12.6 (95% CI; 5.4, 29.4), and negative likelihood ratio (NLR) of 0.48 (95% CI 0.31, 0.75). Sperm DFI of ≥26.1% had
prevalence ratio of 2.84 (95% CI 1.86, 4.33) for the occurrence of male infertility.
Conclusion: There was significant difference between the median value of sperm DFI of infertile men and fertile men.
Compared to semen analysis, sperm DFI at cut-off point of 26.1% has a higher diagnostic value (AUC).
Keywords: Cut-off point, Male infertility, Halosperm®, Semen analysis, Sperm chromatin dispersion (SCD), Sperm DNA
fragmentation index
Résumé
Objectif: Développer une méthode diagnostique e prédiction de l’infécondité masculine.
Matériel et Méthodes: il s’agit d’une étude transversale. Les données ont été extraites des dossiers médicaux de la
Yasmin IVF Clinic Dr Cipto Mangunkusumo General Hospital et de la Daya.
Medika Infertility Clinic, de janvier à décembre 2015. Les sujets ont été sélectionnés par échantillonnage consécutif et
divisés en deux groupes : infécond et fécond. L’indice de fragmentation de l’acide désoxyribonucléique (DFI) a été
déterminé par la méthode de la dispersion de la chromatine spermatozoïdaire (SCD) en utilisant le kit Halosperm™.
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Résultats: Cent quatorze sujets ont été sélectionnés dans cette étude : 36 féconds et 78 inféconds. Aucune différence
significative n’a été retrouvée pour l’âge entre les deux groupes. La valeur médiane du DFI spermatozoïdaire dans le
groupe infécond était significativement plus élevée, 29.9% (IQ1-IQ3 = 26.6–34.3%), que celle du groupe fécond, 19,90%
(15.6–24.4%; P < 0.001). L’aire sous la courbe (AUC) du DFI spermatozoïdaire, 0.862 (95% CI 0.783, 0.941), était plus grande
que celle de la concentration (AUC 0.744; 95% CI 0.657, 0.831), mobilité (AUC 0.668; 95% CI 0.572, 0.765), et morphologie
(AUC 0.718; 95% CI 0.697, 0.864) des spermatozoïdes retrouvées à l’analyse du sperme. Pour une valeur seuil de 26,1%, le
DFI spermatozoïdaire a une sensibilité de 80.8% (95% CI; 70.0, 88.5%), une spécificité de 86.1% (95% CI; 69.7, 94.8%), une
valeur prédictive positive (PPV) de 92.6% (95% CI; 83.0, 97.3%), une valeur prédictive négative (NPV) de 67,4% (95% CI; 51.
9, 80.0%), un ratio de probabilité positive (PLR) de 12,6 (95% CI; 5.4, 29.4), et un ratio de probabilité négative (NLR) de 0.
48 (95% CI 0.31, 0.75). Un DFI spermatozoïdaire≥ 26,1% a un ratio de prévalence de 2,84 (95% CI 1.86, 4.33) pour la
survenue d’une infécondité masculine.
Conclusion: La valeur médiane du DFI spermatozoïdaire diffère significativement entre les féconds et les inféconds. Par
comparaison aux paramètres spermatiques de l’analyse du sperme, un DFI spermatozoïdaire à une valeur seuil de 26,1%
possède une plus grande valeur diagnostique (AUC).
Mots-clés Valeur seuil, Infécondité masculine, Halosperm™, Analyse de sperme, Dispersion de la chromatine
spermatozoïdaire (SCD), Indice de fragmentation de l’ADN spermatozoïdaire
Background
The incidence of infertility ranges from 10 to 20% in the
world. This figure is similar with the data in Indonesia,
where there are 39.8 million couples of childbearing age
with 3.98 million (10–15%) experiencing infertility [1].
The success of a pregnancy is influenced by both men
and women. Of all infertility cases, nearly 50% are due
to male factor of infertility, either as a single factor or as
a combination with female factor [2]. A study conducted
by Wiweko, et al., found that male factor had a role in
43.9% of 266 infertile couples in Indonesia [3]. Male in-
fertility is determined by the quality of the spermatozoa,
which affects the ability for fertilization. In infertility
cases, semen analysis that evaluates sperm concentra-
tion, motility, and morphology is done as a standard
diagnostic tool to assess sperm quality. Damage to the
sperm’s DNA has been studied lately as it is associated
with reduced fertilization rates, embryo quality, and
pregnancy rates, as well as higher rates of spontaneous
miscarriage [4, 5]. A recent study, which studied the re-
lationship between sperm DNA fragmentation in 203
couples underwent In Vitro Fertilization (IVF) and 136
couples underwent Intracytoplasmic Sperm Injection
(ICSI), found that following the IVF, couples with <25%
sperm DFI had a live-birth rate of 33% while couples
with >50% DFI had only 13% birth rate. On the contrary,
following the ICSI, there was no significant difference
between both groups [6]. Live-birth rate increased sig-
nificantly in couples with low sperm DFI compared to
those with high sperm DFI (RR 1.17, 95% CI 1.07, 1.28;
p = 0.0005) in a systematic review and meta-analysis [7].
Therefore, undetected sperm DNA damage could affect
the outcome of Assisted Reproductive Technology
(ART) and also potentially become a stumbling block in
ART making the success rate relatively low, about 20–40%
[3]. It also indicates that semen analysis is not optimal to
detect male infertility, so that there is an opportunity to
use a new predictive factor as a better diagnostic tool. Ac-
ridine orange test, Terminal deoxynucleotidyl transferase
dUTP nick-end labeling (TUNEL) assay, Comet assay,
sperm chromatin structure assay (SCSA), and sperm chro-
matin dispersion (SCD) are some methods commonly
used to identify sperm DNA fragmentation. TUNEL assay
is considered as the most superior method of all other
methods, yet it needs more advanced equipment and high
cost [8]. Chohan (2006) concluded that SCD had positive
correlation with TUNEL assay results that they had similar
predictive values, only SCD was a simpler and a low-cost
method [9]. Another study by Zhang (2010) found that
SCD was more sensitive than TUNEL assay to detect
sperm with DNA fragmentation [10]. This study used
Halosperm® Kit, which is a more accurate and efficient
form of SCD method [11].
Methods
Patients
This study used a cross-sectional design. The data was
retrieved from patient’s medical records of two infertility
clinics in Jakarta (Yasmin IVF Clinic of Dr. Cipto Man-
gunkusumo General Hospital and Daya Medika Infertil-
ity Clinic) since January 2015 to December 2015. In this
study, there were two groups of male subjects, infertile
and fertile. The infertile group was obtained from cou-
ples who had undergone infertility workup with abnor-
mal semen analysis (except azoospermia) and no cause
of infertility in the female partner, while the fertile group
was obtained from men proven to have a living child,
taken from secondary infertile couples with abnormalities
Wiweko and Utami Basic and Clinical Andrology  (2017) 27:1 Page 2 of 7
only in the female factor. Informed consent was obtained
before all subjects recruited into this study. Ethical clear-
ance was approved by Ethical Committee Faculty of Medi-
cine Universitas Indonesia. From the sample size
calculation, it was determined a minimum sample size of
110 subjects. Potential confounding factors, such as smok-
ing, scrotal heat-exposure jobs, history of varicocele, can-
cer, genitourinary tract and gland infection, were obtained
from the medical history and the examination results cited
in the medical records. The last five conditions mentioned
above were excluded from this study. Exclusion also ap-
plied for azoospermia as sperm DFI determination could
not be performed.
Semen analysis
After 7 days of abstinence, a complete sample of neat
ejaculate produced by masturbation in a room in the la-
boratory was collected into a sterile container. In the first
30 min after the collection, sperm concentration was deter-
mined by using counting chamber technique, while wet
preparation for sperm motility and eosin-stained for vitality
determination were prepared. The slides were examined
with phase-contrast optics at x400 magnification and only
morphologically normal spermatozoa were assessed. An
air-dried, fixed, and Giemsa-stained preparation was made
for sperm morphology determination by using bright-field
optics. The prominent semen analysis parameters in this
study were sperm concentration, motility, and morphology
by referring to the World Health Organization (WHO)
standards 2010 [12]. The sperm DFI was determined by
SCD test using Halosperm® Kit. Both determinations,
semen analysis and sperm DFI, were carried out by the
same expert.
Statistical analysis
Statistical analysis was performed using SPSS version 23.
Descriptive method was used to determine the distribu-
tion of the demographic profiles and the risk factors. Lo-
gistic regression was done to assess the smoking habit as
the potential confounding factor. Due to the normality
test of Kolmogorov-Smirnov showed abnormal data distri-
bution, the Mann Whitney test was used to determine the
association of semen parameters (concentration, motility,
or morphology) and sperm DFI with male infertility.
Categorization of sperm DFI was based on the cut-off
point obtained from the Receiver Operating Characteristic
(ROC) curve of sperm DFI.
Results
From the medical records, it was obtained a total of 114
subjects fulfilling the study criteria. Subjects were di-
vided into two groups: 78 of infertile group and 36 of
fertile group. The median and range of age were 34 (32–
39) years old in infertile group and 37 (35–41) years old
in fertile group. Age did no significantly differ between
fertile and infertile groups (p = 0.310). Smoking habit
was not considered as confounding factor in this study
based on logistic regression result (p = 0.401). Infertile
group had a significantly higher median value of sperm
DFI 29.9 (26.6–34.3)% compared to fertile group 19.9
(15.6–24.4)% with p < 0.001. With the same abstinence/
delay in both groups, the values of sperm concentration,
total motility, progressive motility, morphology, and
total sperm count were significantly lower in the infertile
group compared to the fertile group, while semen vol-
ume did not differ between these two groups (Table 1).
The ability of sperm DFI and semen analysis (concen-
tration, motility, and morphology) to diagnose male in-
fertility was described by ROC curve (Fig. 1). AUC of
sperm DFI was 0.862 (95% CI 0.783, 0.941), which was
higher than concentration (AUC of 0.744; 95% CI 0.657,
0.831), motility (AUC of 0.668; 95% CI 0.572, 0.765), and
morphology (AUC of 0.718; 95% CI 0.697, 0.864) of
semen analysis (Table 2).
The highest sensitivity and specificity for sperm DFI
was found at the cut-off point of 26.1%. With this cut-
off point, sperm DFI was able to distinguish infertile
men from fertile men with sensitivity of 80.8% (95% CI;
70.0, 88.5), specificity of 86.1% (95% CI; 69.7, 94.8), posi-
tive predictive value of 92.6% (95% CI; 83.0, 97.3), nega-
tive predictive value of 67.4% (95% CI; 51.9, 80.0),
positive likelihood ratio of 12.6 (95% CI; 5.4, 29.4), and
negative likelihood ratio of 0.48 (95% CI 0.31, 0.75), as
contained in Table 3. Logistic regression showed that
sperm DFI of ≥26,1% has a prevalence ratio of 2.84 (95%
CI; 1.86, 4.33) for infertility.
Discussion
The total number of subjects in the present study was
relatively small, yet it fulfilled the minimal number
Table 1 Comparison of semen parameters and sperm DFI







Abstinence (days) 7 7
Vol (ml) 3.8 (2.8–3.6) 3.0 (2.1–3.4) 0.261
Con (x106/ml) 49.0 (27.3–96.3) 15.3 (7.8–57.5) <0.001
PR + NP (%) 53.9 (45.1–64.9) 40.6 (24.7–60.1) <0.001
PR (%) 46.7 (37.3–60.8) 33.4 (26.2–34.1) <0.001
Morph (%) 24.5 (19.0–50.5) 11.0 (3.0–22.0) <0.001
Total count (x106) 151.1 (86.5–540.0) 45.6 (25.0–302.0) <0.001
Sperm DFI (%)a 19.9 (15.6–24.4) 29.9 (26.6–34.3) <0.001
Vol semen volume, Con sperm concentration, PR progressive motility, NP non-
progressive motility, Morph morphology
a Numeric data with abnormal distribution were presented by median
(Q1-Q3) value
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required from the sample size calculation. From the
demographic data, there was no significant difference in
the age between the two groups. Aging is responsible for
a general decrease in the function of tissues and organs,
including the reproductive tissues and organs. The ef-
fects of aging on male fertility were studied by numerous
studies. Robertshaw, et al., found that advanced paternal
age has an adverse impact on ART outcomes [13]. Other
study also found that the ability of spermatozoa to per-
formed fertilization is inversely correlated with the age
[14]. The effects of paternal age on fertility remain con-
troversial. Wu, et al., found that increased paternal age
had no impact on fertilization rate, embryo quality, and
miscarriage rate after controlling the maternal age [15].
Ferreira, et al., who conducted a study to 1024 couples
undergoing ICSI (intracytoplasmic sperm injection), also
found no correlation between paternal age and sperm
parameters or pregnancy rate [16]. Alfaraj and Yunus
conducted a study to 451 couples and also found that
advancing paternal age had no significant correlation
with the outcomes of semen analysis parameters and
IVF in infertile couples [17]. This study found no signifi-
cant difference between age of the two groups. This
might be caused by the subject’s selection method used
in this study. The fertile group was taken from men
proven to have living children and obtained from sec-
ondary infertile couples due to female factors so that the
median and the range of the age were similar between
the two groups.
We define the fertile men were those who have normal
semen parameter (concentration, motility, and morph-
ology), even though the subsequent subfertility condition
might have correlated with the male factor that can not
be seen in semen analysis result, such as body mass
index (BMI). Although the data about male’s BMI were
not provided, but it has been under a lot of suspicion as
the cause of male infertility. There are emerging facts
confirming that obesity negatively affects male repro-
ductive potential not only by reducing sperm quality,
but in particular, by altering the physical and molecular
structures of germ cells in the testes, and ultimately by
affecting the maturation and functions of sperm cells
[18]. Anifandis, et al., found that BMI of men did not
correlate with sperm parameters, but influenced the
quality of the produced embryos which, in turns, influ-
enced the pregnancy rates [19]. Similar result was also
found by Petersen, et al., that showed couples with both
partners having BMI > 25 kg/m2 had the lowest odds of
Fig. 1 ROC curve of a semen analysis compared to b sperm DFI to diagnose male infertility. The three semen parameters: 1) concentration, 2)
motility, and 3) morphology have lower AUC compared to sperm DFI
Table 2 AUC comparison of sperm DFI and semen parameters
according to the 36 fertile and 78 infertile men
AUC p 95%CI
DFI 0,862 <0,001 (0,783–0,941)
Con 0,744 <0,001 (0,657–0,831)
Mot 0,668 <0,05 (0,572–0,765)
Morph 0,718 <0,001 (0,697–0,864)
DFI DNA fragmentation index, Con sperm concentration, Mot sperm motility,
Morph sperm morphology, AUC area under curve, CI confidence interval
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live birth when compared to couples with both partners
having BMI < 25 kg/m2 in IVF [20]. In contrast with
those studies, Kupka, et al., retrospectively analyzed data
retrieved from the National German IVF Registry, which
covered 12 years and included 650,452 cycles, and found
that the highest clinical pregnancy rates for both IVF
and ICSI were seen in normal weight females with obese
male partners (P = 0.0028) [21]. However, because none
of those studies were randomized controlled trials, sev-
eral potential confounders and biases might have influ-
enced the findings.
This study found that sperm concentration, total motil-
ity, progressive motility, morphology, and total sperm
count values were significantly lower in the infertile group
compared to the fertile group, while semen volume did not
differ. Although total sperm count, total motility, and pro-
gressive motility were significantly lower in infertile group,
the median values were considered normal. It was consid-
ered that the normal median value of the total sperm count
could be the result of the length of abstinence. Both groups
have abstinence/delay of 7 days. The recommended abstin-
ence delay for semen analysis are 2–7 days [12]. Many
studies found that semen volume and concentration (re-
sulted in total sperm count) increased with the increasing
length of abstinence. Carlsen, et al., studied 419 semen
samples with abstinence interval of 2–7 days and found
that there was increased in semen volume and concentra-
tion after 4 days of abstinence and succeeding days, and
there was no effect on motility and total motile spermato-
zoa with increased duration of abstinence [22]. Sunanda, et
al., studied 730 men with abstinence interval of 2–7 days
and found that semen volume and total count increased
with the increasing abstinence period, while sperm motility
and vitality declined after 5 days of abstinence [23]. The ef-
fects of abstinence length on sperm motility in previous
studies were contradicted by a more recent study by
Agarwal, et al., who conducted semen analysis by grouping
the abstinence interval into three categories: short interval
(1 day), the recommended interval of the World Health
Organization (WHO) (2–7 days), and long interval (9–11
days). The study found significant increase in volume, total
sperm count, total motility, and DNA fragmentation be-
tween the short and the recommended abstinence interval
(P < .05); and between the recommended and the long ab-
stinence interval (P < .05) [24].
In this study, the median value of sperm DFI was sig-
nificantly higher in the infertile group compared to the
fertile group (Table 1). The values of the three sperm pa-
rameters are also significantly lower in the infertile
group. These results are consistent with the study of Ser-
gerie, et al., in 2005 that found mean value of sperm DFI
in the infertile group was significantly higher than in the
fertile group (40.9 ± 14.3% compared to 13.1 ± 7.3%) and
the mean sperm concentration in infertile group also
significantly lower compared to the fertile group (62.9 ±
33.2 × 106/ml compared to 102.4 ± 66.4 × 106/ml) [25].
Similar result was also reported in a study that assessed
the degree of DFI in patients dealing with infertility.
Sperm DFI was significantly higher in patients with in-
fertility compared to those of control (22.2 ± 5.6% vs.
16.7 ± 0.7%; p < 0.05) [26]. From these results, it may be
concluded that sperm DFI determination could be used
to distinguish infertile men from fertile men.
AUC value of sperm DFI was 0.862 (p < 0.001; 95% CI
0.783, 0.941) with sensitivity of 80.8% and specificity of
86.1%. Statistically, AUC value in the range of 80–90%
has a good diagnostic strength [27]. This value is 11.8%
higher than the highest AUC value of semen analysis
that routinely performed in infertility workup (Table 2).
This result indicates that clinically, sperm DFI has better
diagnostic strength than semen analysis. Sperm DFI also
has a stronger predictive value compared to free sperm
DNA for the success of pregnancy in IVF and ICSI pa-
tients (AUC = 0.7; p < 0.05 compared to AUC = 0.6; p >
0.05) [28]. A meta-analysis by Cui, et al., also supports
this result that the sperm DFI may be used to distinguish
the sperm of infertile men from fertile men with AUC
value of 0.921, and sensitivity of 80% and specificity of
83% [29].
The expected benefit of this study is to increase the
outcome of infertility management in infertile couple
population. Sperm DFI can well-distinguish infertile
men from fertile men with positive predictive value of
92.6% at 26.1% cut-off point. Similar result was reported
in a study comparing DNA fragmentation of neat and
swim-up spermatozoa to predict pregnancy following
ICSI. The cut-off value of the neat spermatozoa that re-
sulted in 80% of pregnancy rate was 26% [30]. There are
only a few published papers that specifically used SCD
test (or Halosperm test) to assess male infertility and re-
ported the correlation with IVF or ICSI outcomes. Two
published papers reported that sperm DFI measured
with Halosperm had no impact on the embryo quality
and the ongoing pregnancy rates in IVF or ICSI. These









PLR NLR AUC p 95% CI
Sperm DFI 26.1 80.8 86.1 92.6 67.4 12.6 0.48 0.862 <0.001 0.783–0.941
sen sensitivity, spec specificity, PPV positive predictive value, NPV negative predictive value, PLR positive likelihood ration, NLR negative likelihood ratio, CI
confidence interval
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studies, however, used different cut-off points from the
present study (30 and 35% DFI) [31, 32]. Due to the
higher cut-off points, the fact that extremely high DNA
damages are associated with total pregnancy failure
should not be ruled out. A new study that uses 26% DFI
as a cut-off point is needed to establish the impact of
sperm DFI measured with Halosperm on male infertility.
In this study, the prevalence ratio for sperm DFI ≥
26.1% was 2.84 (95% CI, 1.86, 4.33). Thus, it may be
concluded that a man with sperm DFI of ≥ 26.1% has
2.84 times greater risk for infertility than men with
sperm DFI of < 26.1%. These results are consistent with
a cohort study that found the most predictive cut-off
point for pregnancy was sperm DFI of > 25.5% with
negative predictive value of 72.7% and the odds ratio for
sperm DFI < 25.5% was 3.6 (95% CI; 1.66, 7.82) [33].
Conclusion
This study discovered a significant difference between
the median value of sperm DFI of infertile and fertile
men. In determining male infertility, the diagnostic value
(AUC) of sperm DFI was higher than the semen analysis.
Sperm DFI of 26,1% was the optimal cut-off point to dis-
tinguish infertile men from fertile men with sensitivity of
80.8%, specificity of 86.1%, positive predictive value of
92.6%, and negative predictive value of 67.4%. Thus, the
determination of sperm DFI can be considered as an
additional diagnostic tool besides the semen analysis be-
fore an infertile couple undergoing an ART. In addition,
in order to decide whether the cut-off point of 26.1%
can be used universally for sperm DFI determination by
SCD method using Halosperm® Kit, it is necessary to
perform further research in a large scale.
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